To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis.
To learn about the use of high dose chemotherapy followed by transplantation using peripheral blood stem cells.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Stanford University School of Medicine
Stanford, California, United States
To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.